Cephalon To Promote Zeneca's Zomig In UK

Cephalon UK Ltd., a subsidiary of Cephalon, Inc., has begun co-promoting Zeneca's Zomig (zolmitriptan) in the United Kingdom for the treatment of migraine. Zomig is an oral treatment for migraine launched in the UK in April 1997. Cephalon will promote Zomig alongside the company's own narcolepsy product, Provigil.

For more information: Cephalon, Inc., 145 Brandywine Pkwy, West Chester, PA 19380, USA. Telephone: 610-344-0200. Fax: 610-738-6643.